Aniling

📍 Badalona, Spain🗓 Founded 2014👥 15 employees💰 Last funded 2014
At Aniling, we are committed to bring advances in the Genomics arena to everyday’s health care and disease prevention. We aim to accelerate the access to scientific advances in genomics and epigenomics by developing technologies with the applicability as prime requirement. Our current work is focused on the improvement of Next Generation Sequencing methods to integrate molecular data into biologically meaning information fulfilling the high quality standards required in clinics. Our company is a spin-off of the Institute of Predictive and Personalized Medicine of Cancer (IMPPC), with full access to shared resources and facilities of the Can Ruti Campus, that includes the Hospital Germans Trias i Pujol, the Autonomous University of Barcelona and six biomedical research institutes (IMPPC, IGTP, IRSICaixa, IJC, Guttmann Institute and ICO).
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2014
Founded
Investor geography1 country
Spain
1
Frequently asked questions
Who invested in Aniling?
Aniling has 1 investor on record on gritt.io, including 1 early-stage backers.
When did Aniling last raise funding?
The most recent investment in Aniling recorded on gritt.io was in 2014.
When was Aniling founded?
Aniling was founded in 2014.
What industry is Aniling in?
Aniling operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Aniling based?
Aniling is headquartered in Badalona, Spain.